“Regenerative medicine holds immense potential to deliver life-saving treatments and cures for patients with various medical conditions,” said Ruchika Nijhara, executive director of TEDCO’s Maryland Stem Cell Research Fund (MSCRF).
The session will feature Jon Rowley, RoosterBio; Patrick Hanley, Children’s National Hospital; Brock Reeves, Eos BioInnovation; Matt Cimino, Maryland Department of Commerce; and Mo Heidaran, Celix Inc. as they discuss the current landscape of regenerative medicine and stem cell technologies. Throughout their discussion, attendees will learn about common obstacles in the regenerative medicine and life science industries including scientific barriers, securing funding, navigating regulations and overcoming manufacturing constraints.